10.98
Anavex Life Sciences Corporation stock is traded at $10.98, with a volume of 762.94K.
It is down -0.72% in the last 24 hours and up +21.59% over the past month.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
See More
Previous Close:
$11.06
Open:
$11.2
24h Volume:
762.94K
Relative Volume:
0.87
Market Cap:
$937.38M
Revenue:
-
Net Income/Loss:
$-43.16M
P/E Ratio:
-19.96
EPS:
-0.55
Net Cash Flow:
$-29.31M
1W Performance:
-1.17%
1M Performance:
+21.59%
6M Performance:
+19.22%
1Y Performance:
+92.29%
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corporation
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AVXL
Anavex Life Sciences Corporation
|
10.98 | 948.98M | 0 | -43.16M | -29.31M | -0.55 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
Jun-23-22 | Initiated | Berenberg | Buy |
Sep-23-21 | Initiated | BTIG Research | Buy |
Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
Jun-18-19 | Initiated | Janney | Buy |
May-16-18 | Resumed | Maxim Group | Buy |
Mar-08-18 | Initiated | ROTH Capital | Buy |
Feb-13-18 | Reiterated | Maxim Group | Buy |
Sep-29-17 | Resumed | Noble Financial | Buy |
Feb-07-17 | Initiated | Noble Financial | Buy |
Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corporation Stock (AVXL) Latest News
What drives Anavex Life Sciences Corp. stock priceRecord-breaking capital gains - PrintWeekIndia
Anavex Life Sciences Corp. Stock Analysis and ForecastFastest return on investment - PrintWeekIndia
What analysts say about Anavex Life Sciences Corp. stockFree Risk Assessment Services - jammulinksnews.com
Is Anavex Life Sciences Corp. a good long term investmentFree Capital Allocation Plans - Autocar Professional
How Anavex Life Sciences Corp. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
What makes Anavex Life Sciences Corp. stock price move sharplyTriple Return With Stability - Newser
Why Anavex Life Sciences Corp. stock attracts strong analyst attentionSafety First Trading Signals - Newser
Anavex Life Sciences (AVXL) Files for $300 Million Stock Offerin - GuruFocus
Anavex Life Sciences Files for $300 Million Stock Sale - MarketScreener
Wealth Enhancement Advisory Services LLC Sells 4,045 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences extends CEO and principal financial officer contracts - Investing.com
Anavex Life Sciences extends CEO and principal financial officer contracts By Investing.com - Investing.com UK
Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health - MSN
Cambridge Investment Research Advisors Inc. Buys 164,792 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp.(NasdaqGS: AVXL) dropped from Russell Microcap Value Index - MarketScreener
Anavex (AVXL) Sees Notable Increase in Borrow Rate | AVXL Stock News - GuruFocus
Anavex Gets Suit Over Rett Syndrome Clinical Trials Nixed - Law360
ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences ... - Bluefield Daily Telegraph
ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Long-Term Investors to Contact the Firm - GlobeNewswire Inc.
Wealth Enhancement Advisory Services LLC Boosts Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. Appoints Ulrich Elben, as Vice President of Preclinical Operations - marketscreener.com
Anavex Life Sciences Approves Key Amendments at Annual Meeting - TipRanks
We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn - Yahoo Finance
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016AVXL - ACCESS Newswire
Cetera Investment Advisers Acquires New Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Bank of America Corp DE Sells 76,485 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Ameriprise Financial Inc. Buys 3,243 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Millennium Management LLC Sells 133,208 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Lessened by BNP Paribas Financial Markets - Defense World
Deutsche Bank AG Has $693,000 Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
D. E. Shaw & Co. Inc. Purchases Shares of 105,130 Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Northern Trust Corp Raises Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
The Manufacturers Life Insurance Company Has $298,000 Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
HC Wainwright Issues Positive Forecast for AVXL Earnings - Defense World
Anavex Life Sciences Corp.'s (NASDAQ:AVXL) largest shareholders are individual investors with 60% ownership, institutions own 37% - Yahoo Finance
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Tower Research Capital LLC TRC Buys 1,708 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Does Anavex's Alzheimer's Drug Actually Confer Benefit Over Three Years? (NASDAQ:AVXL) - Seeking Alpha
Anavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlight - GuruFocus
Anavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlights: Promising Alzheimer's Data ... - Yahoo Finance
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2025 Earnings Call Transcript - Insider Monkey
Anavex Life Sciences to Participate at Upcoming Healthcare Confe - GuruFocus
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences | AVXL Stock News - GuruFocus
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences - The Manila Times
Anavex Brings Alzheimer's and Parkinson's Drug Updates to Prestigious Wainwright Healthcare Conferences - Stock Titan
Anavex Life Sciences: Fiscal Q2 Earnings Snapshot - CT Insider
Anavex Life Sciences Reports Q2 2025 Financial Results - TipRanks
Raymond James Financial Inc. Makes New $167,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corporation Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):